DIVD - ETF AI Analysis

Top Page

Altrius Global Dividend ETF Altrius Global Divid ETF (DIVD)

Rating:70Neutral

Price Target:―

The Altrius Global Dividend ETF (DIVD) demonstrates a balanced performance, driven by strong contributions from holdings like Novartis (NVS) and AstraZeneca (AZN), both of which benefit from robust financial performance, positive earnings calls, and bullish technical indicators. However, weaker holdings such as British American Tobacco (BTI), which faces earnings volatility and revenue decline, slightly weigh on the fund's overall rating. Investors should also note the potential risks of sector concentration, as several top holdings are in pharmaceuticals and financials, which could impact diversification.

Positive Factors

Strong Top Holdings

Several of the ETF's largest positions, such as Siemens AG and Banco Bilbao, have delivered strong year-to-date performance, supporting overall returns.

Sector Diversification

The ETF is spread across 10 different sectors, reducing the risk of being overly reliant on one industry.

Reasonable Expense Ratio

The fund has a relatively low expense ratio compared to many actively managed ETFs, helping investors keep more of their returns.

Negative Factors

High Geographic Concentration

With over 97% of its exposure in U.S. companies, the ETF lacks diversification across global markets.

Underperforming Holdings

Some top holdings, such as Sanofi and Royal Bank of Canada, have shown weaker year-to-date performance, which may drag on overall returns.

Small Asset Base

The ETF has relatively low assets under management, which could lead to higher trading costs and less liquidity for investors.

DIVD vs. SPDR S&P 500 ETF (SPY)

AUM14.29M

RegionGlobal

Expense Ratio0.49%

Beta0.57

IssuerAltrius

Inception DateSep 29, 2022

Dividend Yield2.77%

Asset ClassEquity

Index TrackedNo Underlying Index

Share Statistics

EPS (TTM)N/A

Shares OutstandingN/A

10 Day Avg. Volume4,034

30 Day Avg. Volume2,826

Financial Highlights & Ratios

PEG RatioN/A

Price to Book (P/B)N/A

Price to Sales (P/S)N/A

P/FCF RatioN/A

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price Target

41.35

Price Target Upside― Downside

Rating ConsensusModerate Buy

Number of Analyst Covering63

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

DIVD Summary

The Altrius Global Dividend ETF (DIVD) is an investment fund focused on companies worldwide that pay strong dividends, making it ideal for investors seeking consistent income and international diversification. It includes well-known companies like Nestlé and GlaxoSmithKline, spanning sectors such as healthcare, consumer goods, and finance. This ETF is a great option for those looking to combine income with growth potential from global markets. However, new investors should be aware that its performance is heavily tied to dividend-paying stocks, which can fluctuate with market conditions.

How much will it cost me?The Altrius Global Dividend ETF (DIVD) has an expense ratio of 0.49%, which means you’ll pay $4.90 per year for every $1,000 invested. This expense ratio is slightly higher than average for ETFs because it is actively managed, focusing on selecting global dividend-paying stocks rather than tracking a passive index.

What would affect this ETF?The Altrius Global Dividend ETF (DIVD) could benefit from global economic growth and increased demand for dividend-paying stocks, especially in sectors like Health Care and Consumer Defensive, which are known for stability and resilience. However, potential risks include rising interest rates, which may make dividend-focused investments less attractive, and geopolitical or regulatory challenges that could impact global markets and specific regions where the ETF is invested. Additionally, sector-specific issues, such as volatility in the Energy or Financial sectors, could negatively affect performance.

DIVD Top 10 Holdings

The Altrius Global Dividend ETF is leaning heavily on global financial and healthcare giants to drive its performance, with names like BBVA and Roche Holding showing steady gains thanks to robust revenue growth and strategic advancements. DHL Group is also rising, benefiting from effective cost management and solid trade operations. However, Capgemini is lagging, weighed down by mixed earnings results and market challenges. The fund’s focus on high-dividend stocks spans multiple sectors, with a notable tilt toward healthcare, consumer defensive, and financials, offering a balanced yet globally diversified income strategy.

Name	Company Name	Weight %	Market Value	Market Cap	Yearly Gain	Overall Rating
RHHBY	Roche Holding	2.56%	$367.03K	$330.53B	50.41%	74 Outperform
BNPQY	BNP Paribas	2.51%	$360.34K	$104.66B	58.73%	72 Outperform
DHLGY	DHL Group	2.39%	$342.82K	$60.60B	55.82%	76 Outperform
BBVA	Banco Bilbao	2.37%	$340.02K	$134.25B	138.34%	76 Outperform
RY	Royal Bank Of Canada	2.34%	$335.92K	$239.11B	41.55%	75 Outperform
CGEMY	Capgemini	2.27%	$325.63K	$28.91B	5.20%	69 Neutral
AZN	AstraZeneca	2.26%	$324.36K	$285.96B	38.08%	79 Outperform
AXAHY	AXA SA	2.25%	$322.71K	$99.86B	36.86%	72 Outperform
NVS	Novartis	2.24%	$322.19K	$263.13B	41.46%	80 Outperform
BTI	British American Tobacco	2.23%	$320.18K	$124.03B	56.56%	59 Neutral

DIVD Technical Analysis

Technical Analysis Sentiment

Positive

Last Price―

Price Trends

50DMA

37.46

Positive

100DMA

36.93

Positive

200DMA

35.55

Positive

Market Momentum

MACD

0.38

Positive

RSI

62.93

Neutral

STOCH

58.03

Neutral

Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For DIVD, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 38.34, equal to the 50-day MA of 37.46, and equal to the 200-day MA of 35.55, indicating a bullish trend. The MACD of 0.38 indicates Positive momentum. The RSI at 62.93 is Neutral, neither overbought nor oversold. The STOCH value of 58.03 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for DIVD.

DIVD Peer Comparison

Comparison Results

Name	Price	Price Target	AUM	Expense Ratio	Overall Rating
DIVD	―	―	$14.29M	0.49%	―
FDIV	―	―	$67.24M	0.35%	―
DIVY	―	―	$28.41M	0.45%	―
GEND	―	―	$28.11M	0.38%	―
VWID	―	―	$14.32M	0.49%	―
GENW	―	―	$3.18M	0.38%	―

Performance Comparison

DIVD

Altrius Global Dividend ETF Altrius Global Divid ETF

38.74

7.82

25.29%

FDIV

MarketDesk Focused U.S. Dividend ETF

―

DIVY

Sound Equity Income ETF

―

GEND

Genter Capital Dividend Income ETF

―

VWID

Virtus WMC International Dividend ETF

―

GENW

Genter Capital International Dividend ETF

―

Glossary

BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―

Table of Contents